Clinical Characteristics of Bacteremia Caused by Extended-spectrum Beta-lactamase-producing <i>Escherichia coli</i> at a Tertiary Hospital-Reference-Cited by-同舟云学术

Clinical Characteristics of Bacteremia Caused by Extended-spectrum Beta-lactamase-producing Escherichia coli at a Tertiary Hospital

Published:2017 Issue:14 Volume:56 Page:1807-1815
ISSN:0918-2918
Container-title:Internal Medicine
language:en
Short-container-title:Intern. Med.

Author:

Namikawa Hiroki¹²,Yamada Koichi¹,Fujimoto Hiroki¹,Oinuma Ken-Ichi³,Tochino Yoshihiro²,Takemoto Yasuhiko²,Kaneko Yukihiro³,Shuto Taichi²,Kakeya Hiroshi¹

Affiliation:

1. Department of Infection Control Science, Osaka City University, Graduate School of Medicine, Japan

2. Department of Medical Education and General Practice, Osaka City University, Graduate School of Medicine, Japan

3. Department of Bacteriology, Osaka City University, Graduate School of Medicine, Japan

Publisher

Japanese Society of Internal Medicine

Subject

General Medicine,Internal Medicine

Link

https://www.jstage.jst.go.jp/article/internalmedicine/56/14/56_56.7702/_pdf

Reference37 articles.

1. 1. Schwaber MJ, Carmeli Y. Mortality and delay in effective therapy associated with extended-spectrum β-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis. J Antimicrob Chemother 60: 913-920, 2007.

2. 2. Paterson DL. Resistance in gram-negative bacteria: Enterobacteriaceae. Am J Med 119 (6 Suppl 1): S20-S28, 2006.

3. 3. Pitout JD, Laupland KB. Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 8: 159-166, 2008.

4. 4. Peterson LR. Antibiotic policy and prescribing strategies for therapy of extended-spectrum beta-lactamase-producing Enterobacteriaceae: the role of piperacillin-tazobactam. Clin Microbiol Infect 14 (Suppl 1): 181-184, 2008.

5. 5. Marchaim D, Gottesman T, Schwartz O, et al. National multicenter study of predictors and outcomes of bacteremia upon hospital admission caused by Enterobacteriaceae producing extended-spectrum beta-lactamases. Antimicrob Agents Chemother 54: 5099-5104, 2010.

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of Different Approaches to Antimicrobial Therapy with Cefmetazole and Meropenem on the Time to Defervescence in Non-Severe Extended-Spectrum β-Lactamase-Producing Escherichia coli Bacteremia;Infectious Disease Reports;2023-12-27

2. Predictors for onset of extended-spectrum beta-lactamase-producing Escherichia coli-induced bacteraemia: a systematic review and meta-analysis;Journal of Hospital Infection;2023-12

3. Targeted Antimicrobial Prophylaxis with Cefmetazole Based on Presence of Fluoroquinolone-Resistant Isolates to Prevent Post-Prostate Biopsy Infectious Complications;Uro;2023-06-09

4. Carbapenem-sparing beta-lactam/beta-lactamase inhibitors versus carbapenems for bloodstream infections caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae: a systematic review and meta-analysis;International Journal of Infectious Diseases;2023-03

5. Empirical treatment and mortality in bacteremia due to extended spectrum β-lactamase producing Enterobacterales (ESβL-E), a retrospective cross-sectional study in a tertiary referral hospital from Colombia;Annals of Clinical Microbiology and Antimicrobials;2023-02-16